These antibodies demonstrated selective binding to AD-derived tau aggregates and no immunoreactivity to aggregates in CBD, PSP, and PiD, providing an additional support to the concept of disease-specific tau conformations [35]. Here, MAPT is linked to supranuclear palsy, progressive, 1.